Skip to main content
Top
Published in: Hereditary Cancer in Clinical Practice 1/2021

Open Access 01-12-2021 | Colorectal Cancer | Research

A rare large duplication of MLH1 identified in Lynch syndrome

Authors: Abhishek Kumar, Nagarajan Paramasivam, Obul Reddy Bandapalli, Matthias Schlesner, Tianhui Chen, Rolf Sijmons, Dagmara Dymerska, Katarzyna Golebiewska, Magdalena Kuswik, Jan Lubinski, Kari Hemminki, Asta Försti

Published in: Hereditary Cancer in Clinical Practice | Issue 1/2021

Login to get access

Abstract

Background

The most frequently identified strong cancer predisposition mutations for colorectal cancer (CRC) are those in the mismatch repair (MMR) genes in Lynch syndrome. Laboratory diagnostics include testing tumors for immunohistochemical staining (IHC) of the Lynch syndrome-associated DNA MMR proteins and/or for microsatellite instability (MSI) followed by sequencing or other techniques, such as denaturing high performance liquid chromatography (DHPLC), to identify the mutation.

Methods

In an ongoing project focusing on finding Mendelian cancer syndromes we applied whole-exome/whole-genome sequencing (WES/WGS) to 19 CRC families.

Results

Three families were identified with a pathogenic/likely pathogenic germline variant in a MMR gene that had previously tested negative in DHPLC gene variant screening. All families had a history of CRC in several family members across multiple generations. Tumor analysis showed loss of the MMR protein IHC staining corresponding to the mutated genes, as well as MSI. In family A, a structural variant, a duplication of exons 4 to 13, was identified in MLH1. The duplication was predicted to lead to a frameshift at amino acid 520 and a premature stop codon at amino acid 539. In family B, a 1 base pair deletion was found in MLH1, resulting in a frameshift and a stop codon at amino acid 491. In family C, we identified a splice site variant in MSH2, which was predicted to lead loss of a splice donor site.

Conclusions

We identified altogether three pathogenic/likely pathogenic variants in the MMR genes in three of the 19 sequenced families. The MLH1 variants, a duplication of exons 4 to 13 and a frameshift variant, were novel, based on the InSiGHT and ClinVar databases; the MSH2 splice site variant was reported by a single submitter in ClinVar. As a variant class, duplications have rarely been reported in the MMR gene literature, particularly those covering several exons.
Appendix
Available only for authorised users
Literature
1.
go back to reference Frank C, Sundquist J, Yu H, Hemminki A, Hemminki K. Concordant and discordant familial cancer: familial risks, proportions and population impact. Int J Cancer. 2017;140:1510–6.CrossRef Frank C, Sundquist J, Yu H, Hemminki A, Hemminki K. Concordant and discordant familial cancer: familial risks, proportions and population impact. Int J Cancer. 2017;140:1510–6.CrossRef
2.
go back to reference Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, et al. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. J Clin Oncol. 2015;33(5):426–32.CrossRef Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, et al. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing. J Clin Oncol. 2015;33(5):426–32.CrossRef
3.
go back to reference Valle L, de Voer RM, Goldberg Y, Sjursen W, Forsti A, Ruiz-Ponte C, et al. Update on genetic predisposition to colorectal cancer and polyposis. Mol Asp Med. 2019;69:10–26.CrossRef Valle L, de Voer RM, Goldberg Y, Sjursen W, Forsti A, Ruiz-Ponte C, et al. Update on genetic predisposition to colorectal cancer and polyposis. Mol Asp Med. 2019;69:10–26.CrossRef
4.
go back to reference Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019;51(1):76–87.CrossRef Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nat Genet. 2019;51(1):76–87.CrossRef
5.
go back to reference Lichtenstein P, Holm N, Verkasalo P, Illiado A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer. N Engl J Med. 2000;343:78–85.CrossRef Lichtenstein P, Holm N, Verkasalo P, Illiado A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer. N Engl J Med. 2000;343:78–85.CrossRef
6.
go back to reference Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, et al. Familial risk and heritability of Cancer among twins in Nordic countries. JAMA. 2016;315(1):68–76.CrossRef Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, et al. Familial risk and heritability of Cancer among twins in Nordic countries. JAMA. 2016;315(1):68–76.CrossRef
7.
go back to reference Cohen SA, Pritchard CC, Jarvik GP. Lynch syndrome: from screening to diagnosis to treatment in the era of modern molecular oncology. Annu Rev Genomics Hum Genet. 2019;20:293–307.CrossRef Cohen SA, Pritchard CC, Jarvik GP. Lynch syndrome: from screening to diagnosis to treatment in the era of modern molecular oncology. Annu Rev Genomics Hum Genet. 2019;20:293–307.CrossRef
8.
go back to reference Kurzawski G, Suchy J, Lener M, Klujszo-Grabowska E, Kladny J, Safranow K, et al. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet. 2006;69(1):40–7.CrossRef Kurzawski G, Suchy J, Lener M, Klujszo-Grabowska E, Kladny J, Safranow K, et al. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet. 2006;69(1):40–7.CrossRef
9.
go back to reference Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M. Okuno S, et al. JAMA Oncol: Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome; 2020. Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M. Okuno S, et al. JAMA Oncol: Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome; 2020.
10.
go back to reference Baert-Desurmont S, Buisine MP, Bessenay E, Frerot S, Lovecchio T, Martin C, et al. Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer. Eur J Hum Genet. 2007;15(3):383–6.CrossRef Baert-Desurmont S, Buisine MP, Bessenay E, Frerot S, Lovecchio T, Martin C, et al. Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer. Eur J Hum Genet. 2007;15(3):383–6.CrossRef
11.
go back to reference Zhang L, Bhaskaran SP, Huang T, Dong H, Chandratre K, Wu X, et al. Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature. Eur J Cancer. 2020;125:12–21.CrossRef Zhang L, Bhaskaran SP, Huang T, Dong H, Chandratre K, Wu X, et al. Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature. Eur J Cancer. 2020;125:12–21.CrossRef
12.
go back to reference Liccardo R, De Rosa M, Rossi GB, Rigler G, Izzo P, Duraturo F. Characterization of novel, large duplications in the MSH2 gene of three unrelated lynch syndrome patients. Cancer Genet. 2018;221:19–24.CrossRef Liccardo R, De Rosa M, Rossi GB, Rigler G, Izzo P, Duraturo F. Characterization of novel, large duplications in the MSH2 gene of three unrelated lynch syndrome patients. Cancer Genet. 2018;221:19–24.CrossRef
13.
go back to reference Duraturo F, Cavallo A, Liccardo R, Cudia B, De Rosa M, Diana G, et al. Contribution of large genomic rearrangements in Italian lynch syndrome patients: characterization of a novel alu-mediated deletion. Biomed Res Int. 2013;2013:219897.CrossRef Duraturo F, Cavallo A, Liccardo R, Cudia B, De Rosa M, Diana G, et al. Contribution of large genomic rearrangements in Italian lynch syndrome patients: characterization of a novel alu-mediated deletion. Biomed Res Int. 2013;2013:219897.CrossRef
14.
go back to reference Kloor M, Sutter C, Wentzensen N, Cremer FW, Buckowitz A, Keller M, et al. A large MSH2 Alu insertion mutation causes HNPCC in a German kindred. Hum Genet. 2004;115(5):432–8.CrossRef Kloor M, Sutter C, Wentzensen N, Cremer FW, Buckowitz A, Keller M, et al. A large MSH2 Alu insertion mutation causes HNPCC in a German kindred. Hum Genet. 2004;115(5):432–8.CrossRef
15.
go back to reference Kurzawski G, Safranow K, Suchy J, Chlubek D, Scott RJ, Lubinski J. Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods. 2002;51(1):89–100.CrossRef Kurzawski G, Safranow K, Suchy J, Chlubek D, Scott RJ, Lubinski J. Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatography. J Biochem Biophys Methods. 2002;51(1):89–100.CrossRef
16.
go back to reference Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.CrossRef Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.CrossRef
17.
go back to reference Smigielski EM, Sirotkin K, Ward M, Sherry ST. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 2000;28(1):352–5.CrossRef Smigielski EM, Sirotkin K, Ward M, Sherry ST. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 2000;28(1):352–5.CrossRef
18.
go back to reference Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.CrossRef Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.CrossRef
19.
go back to reference Liu X, Wu C, Li C, Boerwinkle E. dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. Hum Mutat. 2016;37(3):235–41.CrossRef Liu X, Wu C, Li C, Boerwinkle E. dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. Hum Mutat. 2016;37(3):235–41.CrossRef
20.
go back to reference Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.CrossRef Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.CrossRef
21.
go back to reference Pedersen BS, Layer RM, Quinlan AR. Vcfanno: fast, flexible annotation of genetic variants. Genome Biol. 2016;17(1):118.CrossRef Pedersen BS, Layer RM, Quinlan AR. Vcfanno: fast, flexible annotation of genetic variants. Genome Biol. 2016;17(1):118.CrossRef
22.
go back to reference Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14(2):178–92.CrossRef Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14(2):178–92.CrossRef
23.
go back to reference Kircher M, Witten DM, Jain P, O'Roak BJ. Cooper GM. A general framework for estimating the relative pathogenicity of human genetic variants. 2014;46(3):310–5. Kircher M, Witten DM, Jain P, O'Roak BJ. Cooper GM. A general framework for estimating the relative pathogenicity of human genetic variants. 2014;46(3):310–5.
24.
go back to reference Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32(5):557–63.CrossRef Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32(5):557–63.CrossRef
25.
go back to reference Plazzer JP, Sijmons RH, Woods MO, Peltomaki P, Thompson B, Den Dunnen JT, et al. The InSiGHT database: utilizing 100 years of insights into lynch syndrome. Familial Cancer. 2013;12(2):175–80.CrossRef Plazzer JP, Sijmons RH, Woods MO, Peltomaki P, Thompson B, Den Dunnen JT, et al. The InSiGHT database: utilizing 100 years of insights into lynch syndrome. Familial Cancer. 2013;12(2):175–80.CrossRef
26.
go back to reference Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D7.CrossRef Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D7.CrossRef
27.
go back to reference Kurzawski G, Suchy J, Debniak T, Kladny J, Lubinski J. Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool. Ann Oncol. 2004;15 Suppl 4:iv283–4. Kurzawski G, Suchy J, Debniak T, Kladny J, Lubinski J. Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool. Ann Oncol. 2004;15 Suppl 4:iv283–4.
28.
go back to reference Dymerska D, Serrano-Fernández P, Suchy J, Pławski A, Słomski R, Kaklewski K, et al. Combined iPLEX and TaqMan assays to screen for 45 common mutations in lynch syndrome and FAP patients. The Journal of molecular diagnostics : JMD. 2010;12(1):82–90.CrossRef Dymerska D, Serrano-Fernández P, Suchy J, Pławski A, Słomski R, Kaklewski K, et al. Combined iPLEX and TaqMan assays to screen for 45 common mutations in lynch syndrome and FAP patients. The Journal of molecular diagnostics : JMD. 2010;12(1):82–90.CrossRef
29.
go back to reference Kunkel TA, Erie DA. DNA mismatch repair. Annu Rev Biochem. 2005;74:681–710.CrossRef Kunkel TA, Erie DA. DNA mismatch repair. Annu Rev Biochem. 2005;74:681–710.CrossRef
30.
go back to reference Gueneau E, Dherin C, Legrand P, Tellier-Lebegue C, Gilquin B, Bonnesoeur P, et al. Structure of the MutLα C-terminal domain reveals how Mlh1 contributes to Pms1 endonuclease site. Nat Struct Mol Biol. 2013;20(4):461–8.CrossRef Gueneau E, Dherin C, Legrand P, Tellier-Lebegue C, Gilquin B, Bonnesoeur P, et al. Structure of the MutLα C-terminal domain reveals how Mlh1 contributes to Pms1 endonuclease site. Nat Struct Mol Biol. 2013;20(4):461–8.CrossRef
31.
go back to reference Tamura K, Kaneda M, Futagawa M, Takeshita M, Kim S, Nakama M, et al. Genetic and genomic basis of the mismatch repair system involved in lynch syndrome. Int J Clin Oncol. 2019;24(9):999–1011.CrossRef Tamura K, Kaneda M, Futagawa M, Takeshita M, Kim S, Nakama M, et al. Genetic and genomic basis of the mismatch repair system involved in lynch syndrome. Int J Clin Oncol. 2019;24(9):999–1011.CrossRef
Metadata
Title
A rare large duplication of MLH1 identified in Lynch syndrome
Authors
Abhishek Kumar
Nagarajan Paramasivam
Obul Reddy Bandapalli
Matthias Schlesner
Tianhui Chen
Rolf Sijmons
Dagmara Dymerska
Katarzyna Golebiewska
Magdalena Kuswik
Jan Lubinski
Kari Hemminki
Asta Försti
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Hereditary Cancer in Clinical Practice / Issue 1/2021
Electronic ISSN: 1897-4287
DOI
https://doi.org/10.1186/s13053-021-00167-0

Other articles of this Issue 1/2021

Hereditary Cancer in Clinical Practice 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine